Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$95.9B
| $349M | 0.06% |
1,991,800
+708,400
| +55% | +$128M |
2020 Q3
17 quarters
|
|
227
Neurocrine Biosciences
NBIX
$14.6B
| $346M | 0.06% |
2,538,109
+773,519
| +44% | +$95.7M |
2022 Q3
9 quarters
|
|
228
CALL
Apollo Global Management
APO
$67.3B
| $346M | 0.06% |
2,096,000
+659,200
| +46% | +$104M |
2013 Q2
46 quarters
|
|
229
CALL
AbbVie
ABBV
$464B
| $345M | 0.06% |
1,942,300
-525,200
| -21% | -$96.6M |
2013 Q2
46 quarters
|
|
230
CALL
Lam Research
LRCX
$435B
| $344M | 0.06% |
4,768,900
-593,100
| -11% | -$45M |
2013 Q2
46 quarters
|
|
231
Cisco
CSCO
$442B
| $343M | 0.06% |
5,794,032
+652,812
| +13% | +$37.3M |
2020 Q1
19 quarters
|
|
232
CALL
United Parcel Service
UPS
$79.1B
| $337M | 0.06% |
2,676,200
-765,000
| -22% | -$101M |
2013 Q2
46 quarters
|
|
233
Dover
DOV
$25.5B
| $337M | 0.06% |
1,795,713
+581,715
| +48% | +$114M |
2024 Q1
3 quarters
|
|
234
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
| $336M | 0.06% |
4,447,000
-1,333,300
| -23% | -$106M |
2016 Q3
33 quarters
|
|
235
DraftKings
DKNG
$9.23B
| $335M | 0.06% |
8,994,041
+2,198,447
| +32% | +$87.2M |
2020 Q1
19 quarters
|
|
236
CALL
PepsiCo
PEP
$172B
| $333M | 0.06% |
2,193,000
-113,000
| -5% | -$18.5M |
2013 Q2
46 quarters
|
|
237
PNC Financial Services
PNC
$88.2B
| $333M | 0.06% |
1,726,776
-1,715,769
| -50% | -$337M |
2021 Q1
15 quarters
|
|
238
Humana
HUM
$46.6B
| $332M | 0.06% |
1,306,619
+789,227
| +153% | +$212M |
2017 Q1
31 quarters
|
|
239
DexCom
DXCM
$32.2B
| $331M | 0.06% |
4,261,441
+3,027,597
| +245% | +$224M |
2013 Q2
46 quarters
|
|
240
PUT
Vistra
VST
$47B
| $330M | 0.06% |
2,393,400
+82,900
| +4% | +$11.5M |
2018 Q3
25 quarters
|
|
241
PUT
Marvell Technology
MRVL
$245B
| $329M | 0.06% |
2,983,100
+1,183,900
| +66% | +$110M |
2013 Q2
46 quarters
|
|
242
Labcorp
LH
$25B
| $328M | 0.06% |
1,430,421
+1,296,573
| +969% | +$297M |
2024 Q3
1 quarter
|
|
243
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.6B
| $328M | 0.06% |
2,381,400
+1,490,900
| +167% | +$218M |
2014 Q1
43 quarters
|
|
244
Wells Fargo
WFC
$243B
| $324M | 0.06% |
4,615,562
+2,510,148
| +119% | +$171M |
2014 Q3
41 quarters
|
|
|
245
PUT
Spotify
SPOT
$97.2B
| $323M | 0.06% |
721,300
-486,800
| -40% | -$208M |
2018 Q2
26 quarters
|
|
246
PUT
American Airlines Group
AAL
$8.57B
| $321M | 0.06% |
18,436,500
-6,059,000
| -25% | -$87.1M |
2013 Q4
44 quarters
|
|
247
Mastercard
MA
$484B
| $319M | 0.06% |
606,468
-429,074
| -41% | -$222M |
2016 Q1
35 quarters
|
|
248
CALL
GE Aerospace
GE
$321B
| $319M | 0.06% |
1,914,100
-1,795,600
| -48% | -$320M |
2013 Q2
46 quarters
|
|
249
CALL
VanEck Gold Miners ETF
GDX
$26.1B
| $319M | 0.06% |
9,402,700
+1,244,400
| +15% | +$47.7M |
2014 Q1
43 quarters
|
|
250
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.6B
| $318M | 0.06% |
746,500
-37,800
| -5% | -$16.4M |
2014 Q1
43 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.